DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Fibromyalgia Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Fibromyalgia Market and Competitive Landscape Highlights - 2016 provides comprehensive insights into Fibromyalgia pipeline products, Fibromyalgia epidemiology, Fibromyalgia market valuations and forecast, Fibromyalgia products sales and competitive landscape in the US.
The research is classified into nine sections - Fibromyalgia overview including etiology, pathophysiology, and diagnosis, Fibromyalgia treatment options, Fibromyalgia pipeline products, Fibromyalgia market analysis comprising of Fibromyalgia epidemiology, key products marketed for Fibromyalgia, market valuations and forecast, products sales and market shares.
Research Scope:
- Fibromyalgia Pipeline: Find out the products in clinical trials for the treatment of Fibromyalgia by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Fibromyalgia Epidemiology: Find out the number of patients diagnosed (prevalence) with Fibromyalgia in the US
- Fibromyalgia Products: Identify key products marketed and prescribed for Fibromyalgia in the US, including trade name, molecule name, and company
- Fibromyalgia Product Sales: Find out the sales revenues of Fibromyalgia products, both branded and generics, in the US
- Fibromyalgia Market Valuations: Find out the market size for Fibromyalgia products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Fibromyalgia Products Market Share: Find out the market shares for key Fibromyalgia products in the US
Key Topics Covered:
- Disease Overview
- Fibromyalgia Treatments
- Fibromyalgia Pipeline
- US Fibromyalgia Epidemiology
- Marketed Drugs for Fibromyalgia in US
- US Fibromyalgia Market Size
- US Fibromyalgia Products Sales
- US Fibromyalgia Market Competitive Landscape
- US Fibromyalgia Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/8935bh/us_fibromyalgia